More MS news articles for Jan 2002

The membrane attack complex of complement causes severe demyelination associated with acute axonal injury

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11751993&dopt=Abstract

J Immunol 2002 Jan 1;168(1):458-65
Mead RJ, Singhrao SK, Neal JW, Lassmann H, Morgan BP.
Complement Biology Group, Departments of. Medical Biochemistry and Pathology, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom. Brain Research Institute, University of Vienna, Vienna, Austria.

Complement is implicated in pathology in the human demyelinating disease multiple sclerosis and in animal models that mimic the demyelination seen in multiple sclerosis.

However, the components of the complement system responsible for demyelination in vivo remain unidentified.

In this study, we show that C6-deficient (C6(-)) PVG/c rats, unable to form the membrane attack complex (MAC), exhibit no demyelination and significantly reduced clinical score in the Ab-mediated experimental autoimmune encephalomyelitis model when compared with matched C6-sufficient (C6(+)) rats.

In C6(+) rats, perivenous demyelination appeared, accompanied by abundant mononuclear cell infiltration and axonal injury.

Neither demyelination nor axonal damage was seen in C6(-) rats, whereas levels of mononuclear cell infiltration were equivalent to those seen in C6(+) rats.

Reconstitution of C6 to C6(-) rats yielded pathology and clinical disease indistinguishable from that in C6(+) rats.

We conclude that demyelination and axonal damage occur in the presence of Ab and require activation of the entire complement cascade, including MAC deposition.

In the absence of MAC deposition, complement activation leading to opsonization and generation of the anaphylatoxins C5a and C3a is insufficient to initiate demyelination.
 

PMID: 11751993 [PubMed - in process]